Researchers are excited about the medication , a groundbreaking dual compound showing remarkable data in clinical trials for body loss . It acts by modulating both systems: GLP-1 and GIP, that , when https://kallumbkvy109615.blog2news.com/41290881/this-new-prospect-for-body-loss